A Comparative Analysis of NOX4 Protein Expression in Malignant and Non-Malignant Thyroid Tumors

The comparative analysis of the expression of the reactive oxygen species-generating NADPH oxidase NOX4 from TCGA data shows that the NOX4 transcript is upregulated in papillary thyroid carcinomas (PTC)-BRAF<sup>V600E</sup> tumors compared to PTC-BRAF<sup>wt</sup> tumors. How...

Full description

Bibliographic Details
Main Authors: Salma Fenniche, Mohamed Oukabli, Yassire Oubaddou, Hafsa Chahdi, Amal Damiri, Abir Alghuzlan, Abdelilah Laraqui, Nadia Dakka, Youssef Bakri, Corinne Dupuy, Rabii Ameziane El Hassani
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Current Issues in Molecular Biology
Subjects:
Online Access:https://www.mdpi.com/1467-3045/45/7/367
_version_ 1797589726652268544
author Salma Fenniche
Mohamed Oukabli
Yassire Oubaddou
Hafsa Chahdi
Amal Damiri
Abir Alghuzlan
Abdelilah Laraqui
Nadia Dakka
Youssef Bakri
Corinne Dupuy
Rabii Ameziane El Hassani
author_facet Salma Fenniche
Mohamed Oukabli
Yassire Oubaddou
Hafsa Chahdi
Amal Damiri
Abir Alghuzlan
Abdelilah Laraqui
Nadia Dakka
Youssef Bakri
Corinne Dupuy
Rabii Ameziane El Hassani
author_sort Salma Fenniche
collection DOAJ
description The comparative analysis of the expression of the reactive oxygen species-generating NADPH oxidase NOX4 from TCGA data shows that the NOX4 transcript is upregulated in papillary thyroid carcinomas (PTC)-BRAF<sup>V600E</sup> tumors compared to PTC-BRAF<sup>wt</sup> tumors. However, a comparative analysis of NOX4 at the protein level in malignant and non-malignant tumors is missing. We explored NOX4 protein expression by immunohistochemistry staining in malignant tumors (28 classical forms of PTC (C-PTC), 17 follicular variants of PTC (F-PTC), and three anaplastic thyroid carcinomas (ATCs)) and in non-malignant tumors (six lymphocytic thyroiditis, four Graves’ disease, ten goiters, and 20 hyperplasias). We detected the BRAF<sup>V600E</sup> mutation by Sanger sequencing and digital droplet PCR. The results show that NOX4 was found to be higher (score ≥ 2) in C-PTC (92.9%) compared to F-PTC (52.9%) and ATC (33.3%) concerning malignant tumors. Interestingly, all C-PTC-BRAF<sup>V600E</sup> expressed a high score for NOX4 at the protein level, strengthening the positive correlation between the BRAF<sup>V600E</sup> mutation and NOX4 expression. In addition, independent of the mutational status of BRAF, we observed that 90% of C-PTC infiltrating tumors showed high NOX4 expression, suggesting that NOX4 may be considered a complementary biomarker in PTC aggressiveness. Interestingly, NOX4 was highly expressed in non-malignant thyroid diseases with different subcellular localizations.
first_indexed 2024-03-11T01:10:40Z
format Article
id doaj.art-67e799913472480c8d8fd00253dcfa18
institution Directory Open Access Journal
issn 1467-3037
1467-3045
language English
last_indexed 2024-03-11T01:10:40Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series Current Issues in Molecular Biology
spelling doaj.art-67e799913472480c8d8fd00253dcfa182023-11-18T18:51:15ZengMDPI AGCurrent Issues in Molecular Biology1467-30371467-30452023-07-014575811582310.3390/cimb45070367A Comparative Analysis of NOX4 Protein Expression in Malignant and Non-Malignant Thyroid TumorsSalma Fenniche0Mohamed Oukabli1Yassire Oubaddou2Hafsa Chahdi3Amal Damiri4Abir Alghuzlan5Abdelilah Laraqui6Nadia Dakka7Youssef Bakri8Corinne Dupuy9Rabii Ameziane El Hassani10Laboratory of Biology of Human Pathologies (BioPatH), Faculty of Sciences, Mohammed V University in Rabat, Rabat 1014, MoroccoService of Anatomical Pathology, Military Hospital of Instruction Mohammed V (HMIMV-R), Rabat 1014, MoroccoLaboratory of Biology of Human Pathologies (BioPatH), Faculty of Sciences, Mohammed V University in Rabat, Rabat 1014, MoroccoService of Anatomical Pathology, Military Hospital of Instruction Mohammed V (HMIMV-R), Rabat 1014, MoroccoService of Anatomical Pathology, Military Hospital of Instruction Mohammed V (HMIMV-R), Rabat 1014, MoroccoGustave Roussy Cancer Campus, Pavillon de Recherche N°2, F-94805 Villejuif, FranceService of Anatomical Pathology, Military Hospital of Instruction Mohammed V (HMIMV-R), Rabat 1014, MoroccoLaboratory of Biology of Human Pathologies (BioPatH), Faculty of Sciences, Mohammed V University in Rabat, Rabat 1014, MoroccoLaboratory of Biology of Human Pathologies (BioPatH), Faculty of Sciences, Mohammed V University in Rabat, Rabat 1014, MoroccoGustave Roussy Cancer Campus, Pavillon de Recherche N°2, F-94805 Villejuif, FranceLaboratory of Biology of Human Pathologies (BioPatH), Faculty of Sciences, Mohammed V University in Rabat, Rabat 1014, MoroccoThe comparative analysis of the expression of the reactive oxygen species-generating NADPH oxidase NOX4 from TCGA data shows that the NOX4 transcript is upregulated in papillary thyroid carcinomas (PTC)-BRAF<sup>V600E</sup> tumors compared to PTC-BRAF<sup>wt</sup> tumors. However, a comparative analysis of NOX4 at the protein level in malignant and non-malignant tumors is missing. We explored NOX4 protein expression by immunohistochemistry staining in malignant tumors (28 classical forms of PTC (C-PTC), 17 follicular variants of PTC (F-PTC), and three anaplastic thyroid carcinomas (ATCs)) and in non-malignant tumors (six lymphocytic thyroiditis, four Graves’ disease, ten goiters, and 20 hyperplasias). We detected the BRAF<sup>V600E</sup> mutation by Sanger sequencing and digital droplet PCR. The results show that NOX4 was found to be higher (score ≥ 2) in C-PTC (92.9%) compared to F-PTC (52.9%) and ATC (33.3%) concerning malignant tumors. Interestingly, all C-PTC-BRAF<sup>V600E</sup> expressed a high score for NOX4 at the protein level, strengthening the positive correlation between the BRAF<sup>V600E</sup> mutation and NOX4 expression. In addition, independent of the mutational status of BRAF, we observed that 90% of C-PTC infiltrating tumors showed high NOX4 expression, suggesting that NOX4 may be considered a complementary biomarker in PTC aggressiveness. Interestingly, NOX4 was highly expressed in non-malignant thyroid diseases with different subcellular localizations.https://www.mdpi.com/1467-3045/45/7/367papillary thyroid carcinomasBRAF<sup>V600E</sup> hot spot mutationNADPH oxidase NOX4biomarker
spellingShingle Salma Fenniche
Mohamed Oukabli
Yassire Oubaddou
Hafsa Chahdi
Amal Damiri
Abir Alghuzlan
Abdelilah Laraqui
Nadia Dakka
Youssef Bakri
Corinne Dupuy
Rabii Ameziane El Hassani
A Comparative Analysis of NOX4 Protein Expression in Malignant and Non-Malignant Thyroid Tumors
Current Issues in Molecular Biology
papillary thyroid carcinomas
BRAF<sup>V600E</sup> hot spot mutation
NADPH oxidase NOX4
biomarker
title A Comparative Analysis of NOX4 Protein Expression in Malignant and Non-Malignant Thyroid Tumors
title_full A Comparative Analysis of NOX4 Protein Expression in Malignant and Non-Malignant Thyroid Tumors
title_fullStr A Comparative Analysis of NOX4 Protein Expression in Malignant and Non-Malignant Thyroid Tumors
title_full_unstemmed A Comparative Analysis of NOX4 Protein Expression in Malignant and Non-Malignant Thyroid Tumors
title_short A Comparative Analysis of NOX4 Protein Expression in Malignant and Non-Malignant Thyroid Tumors
title_sort comparative analysis of nox4 protein expression in malignant and non malignant thyroid tumors
topic papillary thyroid carcinomas
BRAF<sup>V600E</sup> hot spot mutation
NADPH oxidase NOX4
biomarker
url https://www.mdpi.com/1467-3045/45/7/367
work_keys_str_mv AT salmafenniche acomparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT mohamedoukabli acomparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT yassireoubaddou acomparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT hafsachahdi acomparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT amaldamiri acomparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT abiralghuzlan acomparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT abdelilahlaraqui acomparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT nadiadakka acomparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT youssefbakri acomparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT corinnedupuy acomparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT rabiiamezianeelhassani acomparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT salmafenniche comparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT mohamedoukabli comparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT yassireoubaddou comparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT hafsachahdi comparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT amaldamiri comparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT abiralghuzlan comparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT abdelilahlaraqui comparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT nadiadakka comparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT youssefbakri comparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT corinnedupuy comparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors
AT rabiiamezianeelhassani comparativeanalysisofnox4proteinexpressioninmalignantandnonmalignantthyroidtumors